Literature DB >> 22298612

Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy?

G Raghu, K C Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22298612     DOI： 10.1183/09031936.00211311

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  23 in total

Review 1.  Idiopathic pulmonary fibrosis in East Asian.

Authors:  Changbo Sun; Yanbin Sun; Hui Shen; Chunlu Yang; Shun Xu
Journal:  Intractable Rare Dis Res       Date:  2017-05

Review 2.  [Interstitial processes of the lungs in childhood].

Authors:  H Popper
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

3.  Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment.

Authors:  Marco E Allaix; Piero M Fisichella; Imre Noth; Fernando A Herbella; Bernardo Borraez Segura; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

Review 4.  Gastroesophageal Reflux and Idiopathic Pulmonary Fibrosis.

Authors:  Marco E Allaix; Fabrizio Rebecchi; Mario Morino; Francisco Schlottmann; Marco G Patti
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

5.  Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.

Authors:  Michael Kreuter; Paolo Spagnolo; Wim Wuyts; Elisabetta Renzoni; Dirk Koschel; Francesco Bonella; Toby M Maher; Martin Kolb; Derek Weycker; Klaus-Uwe Kirchgässler; Ulrich Costabel
Journal:  Respiration       Date:  2017-04-12       Impact factor: 3.580

Review 6.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

7.  Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

Authors:  Joyce S Lee; Harold R Collard; Kevin J Anstrom; Fernando J Martinez; Imre Noth; Rhonda S Roberts; Eric Yow; Ganesh Raghu
Journal:  Lancet Respir Med       Date:  2013-06-14       Impact factor: 30.700

Review 8.  Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.

Authors:  Yohannes T Ghebre; Ganesh Raghu
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

Review 9.  Diagnosis and management of interstitial lung disease.

Authors:  Keith C Meyer
Journal:  Transl Respir Med       Date:  2014-02-13

10.  Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Chang Min Lee; Dong Ho Lee; Byung Kyu Ahn; Jae Jin Hwang; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  J Neurogastroenterol Motil       Date:  2016-07-30       Impact factor: 4.924
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.